{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:06:46Z","timestamp":1771952806821,"version":"3.50.1"},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Safety"],"published-print":{"date-parts":[[1998]]},"DOI":"10.2165\/00002018-199818010-00005","type":"journal-article","created":{"date-parts":[[2006,1,21]],"date-time":"2006-01-21T10:00:35Z","timestamp":1137837635000},"page":"57-82","source":"Crossref","is-referenced-by-count":68,"title":["Risks and Benefits of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression"],"prefix":"10.2165","volume":"18","author":[{"given":"Patricia","family":"Mourilhe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter E.","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["Drug Safety"],"original-title":[],"language":"en","deposited":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T14:17:28Z","timestamp":1455027448000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00002018-199818010-00005"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1998]]},"references-count":0,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.2165\/00002018-199818010-00005","relation":{},"ISSN":["0114-5916"],"issn-type":[{"value":"0114-5916","type":"print"}],"subject":[],"published":{"date-parts":[[1998]]}}}